News-Victory for Citrulline-01-2015

by | Jan 1, 2015

Post Categories: Health Conditions

Law Firm Wins Major Victory for Citrulline Case

Patent attorney William R. Trueba Jr., a founding member of the intellectual property law firm of Espinosa Trueba, argued a motion for summary judgment on behalf of a joint defense group before a California federal judge, obtaining a ruling that invalidated all asserted claims of two nutritional supplement patents by a nonpracticing entity (NPE).

“This ruling sends a clear message that defending against meritless patent infringement claims may be the better approach over settling,” said Trueba. “This is a major victory for the client and it illustrates the positive risk/benefit analysis between settling and defending on the merits when you know that the patents should never have been granted in the first place.” Late in 2013, the US House of Representatives passed a bill to curb infringement lawsuits by NPEs, and the Senate was also considering additional legislation earlier this year.

On June 13, 2014, the Honorable Judge S. James Otero of the US District Court for the Central District of California ruled from the bench memorializing his decision. This decision strikes a huge setback against the Tawnsaura Group, a well-known California NPE who filed suit in mid-2012 against over 85 defendants that sell nutritional supplements nationwide. Judge Otero has taken a strong interest in patent infringement cases and is a founding member of the Judge Michel Intellectual Property American Inn of Court and is a Central District Patent Pilot Judge. Judge Otero has sat by designation on the US Courts of Appeals for the Federal Circuit, the appellate court that hears all patent appeals. He has also been a panel speaker for the Federal Circuit Bar Association, the American Bar Association Section of Intellectual Property Law, the Intellectual Property Law Section of the State Bar of California, American Business Trial Lawyers, the Los Angeles Intellectual Property Law Association, and the NAPABA Convention on Patent Damages.

After filing suit, Otero effectively consolidated the cases for purposes of streamlining the pretrial activities in the various cases, thus causing the creation of a joint defense group representing the various defendant companies. Throughout that time, dozens of the defendant companies settled with the Tawnsaura Group, paying the NPE licensing fees. Based upon the judge’s pretrial schedule, the defendants jointly filed a motion for summary judgment seeking to invalidate the patent claims at issue in the two patents. Trueba and two other attorneys were chosen by the joint defense group of remaining defendants to divide the topics and argue the motion for summary judgment. In the days leading up the hearing, there was a flurry of settlement discussions between the Tawnsaura Group and various defendants. Two days prior to the argument, the two other attorneys designated to argue informed Trueba that their clients had in fact settled and they would not participate in the argument. Trueba reviewed the other two attorneys’ topics and argued the motion. During the hearing, the judge issued a positive ruling from the bench, an uncommon occurrence in a patent infringement lawsuit. The court held that the various patent claims being asserted were invalid on the basis of prior technology and prior knowledge of the claimed methods.

In this matter, Trueba represented Vitacost.com Inc. (NASDAQ: VITC), a leading online retailer of health and wellness products, including dietary supplements. Tawnsaura alleged that Vitacost.com’s sales of a vitamin supplement called L-citrulline, whose benefits on the human body were well known for many years prior to the inventor applying for his two patents, infringed Tawnsaura’s patent rights. During the course of the case, the defendants uncovered information that showed that the methods of administering L-citrulline claimed in the patents had already been practiced and used many years prior to the critical date of the patents. In fact, the defendants also learned that the named inventor of the patents, Dr. William Waugh, had attempted to publish an article on his purported discoveries, but the publication rejected the article on the basis that his disclosure did not provide any information that was not already well known.

Furthermore, defendants learned that Waugh was made aware of the commercial sales of Stimol by a French company in the early 1990s. Stimol was an L-citrulline-based supplement that was provided to patients. Waugh failed to inform the US Patent and Trademark Office about these particular events, though he had a duty to do so. Thus, the defendants asked for judgment in their favor stating that the relevant portions of two patents were invalid in view of the preexisting knowledge and use of the claimed inventions.

Earlier this year, the judge in the case asked the parties to provide supplemental briefing on the issue of whether the claimed inventions were invalid on the basis that the difference between inventions and the prior use of L-citrulline was “obvious” to those skilled in the technology. The parties did so, and the matter proceeded to oral argument. Trueba’s practice focuses on the domestic and international enforcement of intellectual property rights. In addition to his electrical engineering academic background, Trueba has practical experience from his years of working in the industry. He is a patent attorney registered with the US Patent and Trademark Office. In addition to litigation, he is also experienced in the prosecution of patent and trademark applications.

The law firm Espinosa Trueba, PL, focuses on litigation and prosecution of trademarks, patents, copyrights, trade secrets, contracts in restraint of trade, customs & border protection, anti-counterfeiting, cloud computing, social networking, computer law and Internet law. For more information, visit www.etlaw.com.

Author

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • 2026 Lifestyle Medicine Conference

    Hybrid Event

    Join us in Orlando, or Online! This event is your gateway to discovering groundbreaking insights from renowned experts at the forefront of healthcare innovation. Total credit opportunities (CME/CE accreditation) for LM2026 are expected to be comparable to prior years across multiple disciplines. Full conference participation will meet—and may exceed—the educational requirements for lifestyle medicine certification.  The annual Lifestyle Medicine Conference unites a dynamic community — online and onsite — committed to reshaping healthcare. Explore how to tackle the root causes of chronic disease and elevate health within every care setting. See why lifestyle medicine can renew your purpose and passion. This year’s agenda explores what it takes to bring lifestyle medicine to life at scale. Learn from clinicians, researchers, health system leaders, educators, and innovators tackling today’s biggest healthcare challenges through evidence-based approaches that improve outcomes, reduce disease burden, and help people thrive.

  • 2026 Annual CoAND Conference & Retreat

    Connect with community to learn & play! After the huge success of having both a retreat and academic style conference last year, we are doing it again, only this time in Manitou Springs! Please join us as we learn from top professionals in our community, engage in hands on learning with our peers, and experience the incredible power of Naturopathic Medicine.  Expert Lectures Classes & Workshops Experiences We have an incredible line up of speakers and presenters for you this year! 

    $399 – $595
  • 2026 Association of Natural Health Conference

    Douglasville Conference Center Douglasville, GA, United States

    "From Practitioner to Leader: Clinical Excellence, Business Mastery & Sustainable Practice" Discover how clinical excellence, business mastery, and sustainable systems can help practitioners grow into confident leaders and build practices designed for long-term impact. Why Attend? Three days of learning, connection, and growth designed for every stage of your practice journey. Learn from Leading Voices Gain insights from top experts in natural health, holistic wellness, and functional medicine. Hands-On Learning Participate in in-depth workshops, real-world case studies, and interactive sessions you can apply immediately. Meaningful Networking Connect with like-minded professionals, students, and exhibitors who share your passion for natural health. Practical Tools & Approaches Explore new strategies and tools to elevate both your practice and your own health journey. Who Should Attend? This conference is built for a wide community of natural health professionals, educators, and advocates - wherever you are in your journey. Licensed & Clinical Practitioners Doctors, chiropractors, acupuncturists, naturopaths, and functional or integrative medicine practitioners looking to sharpen clinical skills and grow into stronger practice leaders. Allied Health Professionals Bio-feedback technicians and other allied practitioners seeking hands-on training and the latest tools in natural and holistic care. Educators & Students Natural health educators and students entering the […]

Related Posts

From Mutation to Metabolism: A Broader View of Cancer Development

By Erik Peper, PhD, BCB, and Richard Harvey, PhD – SMT framework has guided the “War on Cancer” and has led to remarkable advances in targeted therapies, chemotherapy, immunotherapy, and radiation treatments. These strategies have saved countless lives, yet they primarily focus on eliminating malignant cells rather than understanding why normal cells become malignant in the first place.

Read More

Berberine Monograph

By Donnie Yance – Berberine is an isoquinoline alkaloid with strong biological and pharmacological activity. It demonstrates significant anticancer activity through multiple biochemical pathways, particularly proapoptotic and anti-inflammatory mechanisms.

Read More

Restore the Gut – A Bio-Electric Chemistry Explanation to Identify the Cause of Everyday Chronic GI Complaints

By Darrell SCS Misak, ND, RPh – Naturopathic medicine has always been right: restore the gut first and you will potentially interrupt the entire cascade before it has the chance to write itself into a patient’s biochemistry or gene expression, and as Dr. Carey Reams himself maintained, into the very deficiencies that underlie all diseases.

Read More

The Kidney Inside the Protocol

By Bismah Irfan, MD – Older adults with the highest ultra-processed food intake had 26% higher incident-CKD risk — 37% when animal-sourced — and its phosphate additives are almost fully absorbed, versus roughly half from plants.

Read More

0 Comments

Submit a Comment